Table 3.
Some examples of nanosolutions for viral diseases, with their examples
| Mechanism of action | Examples |
|---|---|
| Nanoparticles that block cell attachment and viral entry |
• Titanium (Ti), silver (Ag), gold (Au), and zinc (Zn) • Cationic carbon dots (CDs) synthesized from curcumin (CCM-CDs) • Curcumin-modified AgNPs (cAgNPs) • Silicon NPs (SiNPs) • Mesoporous-SiO2 (mSiO2) • Selenium NPs • Graphene QDs can inhibit cell binding of HIV • GO and its derivatives |
| Nanoparticles that block viral replication and proliferation |
• AgNPs and SeNPs • AuNPs • Ag2S • Benzoxamine monomer–derived CDs |
| Nanoparticles for viral inactivation and viricidal treatment |
• • AuNPs • • Decoy virus receptor-functionalized nanodiscs • • Ferromagnetic Fe3O4 • AuNPs |
| Antiviral agent delivery |
• Nanoencapsulation • Polymeric NPs • Gold nanoparticle-peptide triazole conjugates • PLGA-based NPs • Cationic liposomal NPs • The virus-mimicking nanoparticles • The polyamidoamines (PAMAMs) |
| Nanomedicine strategies to target the immune system |
• Tocilizumab (an IL-6 antagonist) plus hyaluronate-gold NPs • Liposomal dexamethasone • LIF nano • Adenosine |
| Nanoparticles combining multiple approaches for treatment |
• Combining carbon QDs (CQDs) • The multifunctional lipid-polymer hybrid nanoformulation • Virus-like particles (VLPs) and virosomes |
| Additional nanosolutions for COVID-19 |
• Regenerative nanomedicine • Mesenchymal stem cell secretome • Exosome |